Jenoptik AG JEN
XETR · Germany · Electronic Technology
€41.40-0.58 (-1.38%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Jenoptik AG (JNPKF) reports a 50% surge in order intake and raises full-year 2026 guidance on robust semiconductor demand.
Jenoptik (ETR:JEN) reported a return to revenue growth and a sharp improvement in profitability in the first half of 2026, supported by demand in its semiconductor-focused operations and strong order activity in Biophotonics. The company also raised the specificity of its full-year outlook, forecast
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Metrology Market size & share revenue was valued at approximately USD 12.5 Billion in 2025 and is expected to reach USD 13.2 Billion in 2026 and is expected to reach around USD 21.9 Billion by 2035, at a CAGR of 5.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Carl Zeiss AG, Pollen Metrology, Cairnh
Jenoptik AG ( ETR:JEN ) is about to trade ex-dividend in the next three days. The ex-dividend date is commonly two...
Shareholders will be ecstatic, with their stake up 32% over the past week following Jenoptik AG 's ( ETR:JEN ) latest...
Jenoptik (ETR:JEN) reported record first-quarter order intake for 2026, driven by a sharp rebound in semiconductor-related demand and stronger biophotonics activity, while revenue was slightly lower year over year and profitability improved. President and CEO Stefan Traeger told analysts that order
Jenoptik (ETR:JEN) highlighted its positioning as a photonics-focused supplier to semiconductor, medical and life science, metrology and smart mobility markets during a presentation at the digital German Select Conference, with Head of IR and Sustainability Andreas Theisen outlining 2025 performance
While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a significant share price rise of...
Jenoptik AG (JNPKF) navigates a complex market with strategic expansions and operational improvements, despite facing revenue declines in key sectors.
Jenoptik (ETR:JEN) management used its fiscal 2025 results call to outline progress on strategic initiatives, discuss a year shaped by a weaker semiconductor lithography environment, and provide guidance for a return to profitable growth in 2026. CFO Dr. Prisca Havranek-Kosicek was joined by Head of
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.